Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Yuekang Pharmaceutical is a core subsidiary of the Yuekang Pharmaceutical Group, located in the Haikou National High-tech Zone in China. The company is a specialized pharmaceutical manufacturer and developer focusing on high-demand therapeutic areas such as cardiovascular health, anti-infectives, and digestive system disorders. Its flagship product, Ginkgo Biloba Extract Injection, is a market leader in China for treating cerebral and peripheral blood flow disturbances. Hainan Yuekang operates sophisticated, GMP-certified production lines capable of producing various dosage forms, including large and small volume injections, tablets, and capsules. As a key component of its parent company's industrial chain, it integrates research, development, and large-scale production to supply both domestic and international markets. The company is recognized as a high-tech enterprise and contributes significantly to the regional pharmaceutical industry in Hainan.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Yuekang Biomedicine.